Tata India Pharma and Healthcare Fund · Regular · Growth
NAV
₹33.0422
as of 29 Sept 2026
Expense Ratio
2.11%
AUM
₹1,359 Cr
Lumpsum returns (CAGR)
- 1Y
- +10.17%
- 3Y
- +17.60%
- 5Y
- +13.11%
- Since Inception
- +11.75%
SIP returns (XIRR)
- 1Y
- +13.22%
- 3Y
- +11.71%
- 5Y
- +15.85%
- Since Inception
- +15.95%
What history actually did — last 10 years (Sept 2016 – Sept 2026)
A ₹5,000 monthly SIP for the last 10 years (Sept 2016 – Sept 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹14,40,432 today — ₹6,00,000 invested, 16.8% XIRR.
₹6,00,000
Invested
₹14,40,432
Value today
16.8%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 10 years (Sept 2016 – Sept 2026)
Real NAV backtest
₹1,00,000 invested 10 years ago would be ₹3,46,678 today (13.2% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Sept 2016 would still hold ₹20,26,345.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹14,40,432 in this fund vs ₹11,24,556 in the benchmark — outperformance of ₹2,98,611.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 10 years (Sept 2016 – Sept 2026) (22 Mar 2020) would be ₹3,99,422 today (3.99×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.56
Sharpe Ratio
+0.09
Alpha
0.18
Beta
0.56
Sortino
11.46%
Std Dev
-11.08%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Pharmaceuticals & Biotechnology58.28%
- Healthcare Services34.07%
- Fertilizers & Agrochemicals5.55%
- Personal Products1.09%
- Insurance0.50%
Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about Tata India Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Ltd8.43%
- 2Healthcare Global Enterprises Ltd6.30%
- 3Divi Laboratories Ltd5.65%
- 4Abbott India Ltd5.44%
- 5Rainbow Childrens Medicare Ltd4.47%
- 6Apollo Hospitals Enterprise Ltd4.32%
- 7Cipla Ltd4.27%
- 8Dr Reddys Laboratories Ltd4.21%
- 9Max Healthcare Institute Ltd3.80%
- 10Fortis Healthcare Ltd3.30%
What this fund does
Tata India Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Tata India Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Tata Mutual Fund. The fund has been operational for over 10 years. It manages assets worth ₹1,359 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE HEALTHCARE. The current expense ratio is 2.11%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •SIP investors who can benefit from rupee cost averaging during market fluctuations